Published in Cancer on June 01, 1990
The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med (1999) 6.16
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. N Engl J Med (2000) 4.50
High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo (1995) 3.25
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med (1982) 1.85
Selection of the optimal skeletal site for fracture risk prediction. Clin Orthop Relat Res (1987) 1.78
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. Clin Cancer Res (2000) 1.74
Prediction of postmenopausal fracture risk with use of bone mineral measurements. Am J Obstet Gynecol (1985) 1.73
A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer. Urology (1998) 1.69
Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. J Clin Oncol (1993) 1.64
Clinical pharmacology of sisomicin. Antimicrob Agents Chemother (1975) 1.61
Natural history study of gallbladder cancer: a review of 36 years experience at M. D. Anderson Hospital and Tumor Institute. Cancer (1978) 1.53
Bone mineral measurements among middle-aged and elderly Japanese residents in Hawaii. Am J Epidemiol (1984) 1.50
Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis. J Immunol (1987) 1.49
Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol (1996) 1.46
In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice. Nat Med (2001) 1.46
Therapeutic trials with tobramycin. Am J Med Sci (1974) 1.44
Segmentation of pulmonary nodules in thoracic CT scans: a region growing approach. IEEE Trans Med Imaging (2008) 1.44
Pharmacology of amikacin in humans. Antimicrob Agents Chemother (1974) 1.43
Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol (1996) 1.43
Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study. J Clin Oncol (1998) 1.42
Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol (2000) 1.41
The role of adjuvant surgery in the combined modality therapy of small-cell bronchogenic carcinoma after a chemotherapy-induced partial remission. J Clin Oncol (1990) 1.40
A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine (Baltimore) (1979) 1.36
Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors. J Immunol (1986) 1.36
Body mass index as a predictor of cancer in men. J Natl Cancer Inst (1985) 1.31
Work site group meetings and the effectiveness of a televised smoking cessation intervention. Am J Community Psychol (1987) 1.29
A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. J Clin Oncol (1984) 1.28
Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients. J Clin Oncol (1995) 1.28
Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192). Am J Clin Oncol (2001) 1.26
Coffee and pancreatic cancer. Lancet (1981) 1.25
Cutaneous and subcutaneous metastases of lung cancer. Clinical characteristics. Postgrad Med (1986) 1.25
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma. Cancer (2001) 1.24
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17. Ann Oncol (2008) 1.24
Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside. Biochem Pharmacol (1983) 1.24
Prospective study of alcohol consumption and cancer. N Engl J Med (1984) 1.23
bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study. J Clin Oncol (1997) 1.23
Prospective evaluation of adrenal insufficiency in patients with adrenal metastasis. Cancer (1987) 1.21
Chemotherapy for metastatic carcinoid tumors: experiences with 32 patients and a review of the literature. Cancer Treat Rep (1977) 1.21
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study. Invest New Drugs (1992) 1.21
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum (2008) 1.20
HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study. Clin Cancer Res (1998) 1.20
Serum vitamin levels and the risk of cancer of specific sites in men of Japanese ancestry in Hawaii. Cancer Res (1985) 1.20
Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea. J Natl Cancer Inst (1994) 1.20
Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors. Ann Oncol (1995) 1.19
Necrotizing colitis in patients with cancer. Am J Med (1979) 1.19
Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. Cancer Res (1988) 1.18
Psychological and behavioral functioning in adolescent psychiatric inpatients who report histories of childhood abuse. Am J Psychiatry (1999) 1.17
Pharmacokinetics of recombinant interleukin 2 in humans. Cancer Res (1990) 1.16
Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology (1986) 1.16
Black tea consumption and cancer risk: a prospective study. Br J Cancer (1986) 1.15
Prospective study of coffee consumption and the risk of cancer. J Natl Cancer Inst (1986) 1.14
Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents. Cancer Res (2001) 1.14
Chronic oral administration of CI-994: a phase 1 study. Invest New Drugs (2001) 1.10
The role of schedule of antibiotic therapy on the neutropenic patient. Infection (1980) 1.09
Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J Natl Cancer Inst (1987) 1.09
Gastric carcinoma in young adults. South Med J (1979) 1.08
Differential effects of thiazide and estrogen upon bone mineral content and fracture prevalence. Obstet Gynecol (1986) 1.08
A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network. Int J Immunopathol Pharmacol (2008) 1.08
Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol (1998) 1.08
Gram-negative bacillary pneumonia in the compromised host. Medicine (Baltimore) (1977) 1.07
Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Lett (2001) 1.07
Amikacin therapy of severe infections produced by gram-negative bacilli resistant to gentamicin. Am J Med Sci (1977) 1.07
Serum pepsinogens I and II and stomach cancer. Clin Chim Acta (1987) 1.07
Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol Res Pract (1995) 1.07
The relationship between diet and bone mineral content of multiple skeletal sites in elderly Japanese-American men and women living in Hawaii. Am J Clin Nutr (1985) 1.06
Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934). Clin Cancer Res (1995) 1.05
Clinical pharmacology of tobramycin. Am J Med Sci (1973) 1.05
Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study). Clin Cancer Res (1998) 1.05
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole. Ann Oncol (2012) 1.05
Amikacin therapy of infections in neutropenic patients. Am J Med Sci (1976) 1.05
The effects of nonresponse in a prospective study of cancer. Am J Epidemiol (1982) 1.05
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. J Antimicrob Chemother (1983) 1.04
Diagnosis and management of infections associated with immunosuppression. New antibiotics of potential importance for immunosuppressed patients. Transplant Proc (1973) 1.04
The origins of epidemiologic studies of heart disease, cancer and osteoporosis among Hawaii Japanese. Hawaii Med J (1985) 1.04
Association of diet and other factors with adenomatous polyps of the large bowel: a prospective autopsy study. Am J Clin Nutr (1988) 1.03
Plasma and cerebrospinal fluid pharmacokinetics of 5-Aza-2'-deoxycytidine in rabbits and dogs. Cancer Res (1983) 1.03
Determination of blood volume using indocyanine green (cardio-green) dye. Life Sci (1968) 1.03
Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected]. J Clin Oncol (1988) 1.02
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers. Ann Oncol (2010) 1.01
Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer. J Clin Oncol (2003) 1.00
Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice. Anticancer Drugs (1996) 1.00
Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol (1984) 0.99
Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Cancer Res (1993) 0.99
Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients. Cancer Res (1994) 0.99
Sarcoma of the stomach: clinicopathologic study of 43 cases. J Surg Oncol (1980) 0.97
Correlates of suicide risk in adolescent inpatients who report a history of childhood abuse. Compr Psychiatry (1999) 0.96
Chemotherapy and chemoimmunotherapy of colorectal cancer. Role of the carcinoembryonic antigen. Surg Clin North Am (1978) 0.96
Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res (1988) 0.96
Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems. Cancer Res (1992) 0.96
Weekly 1-hour infusion of paclitaxel. Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma. Cancer (2000) 0.96
Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer. J Clin Oncol (1994) 0.96
Dihydroxyanthracenedione: a promising new drug in the treatment of metastatic breast cancer. Ann Intern Med (1981) 0.95